PHARMACEUTICAL ECONSULTING A/S: Financial statements 2015
CVR: 30815378
Source: annual report 2015, Danish Business Authority
01/10/2014 – 30/09/2015
PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2015 report amounted to DKK 0.
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | 0 | 0 | - |
| 2014 | - | - | 0 | 0 | - |
| 2013 | - | - | 0 | 0 | - |
| 2012 | - | -1.8 mio. | 397 t. | -1.3 mio. | - |
Official annual report
How creditworthy is PHARMACEUTICAL ECONSULTING A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of December 31, 2015, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of December 31, 2015, Jens Christian Pii Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of December 30, 2015, Hanne Laurberg Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2014. The net result was DKK 0.
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.